SPEXIB or Ceritinib 150 mg. is supplied for Tenders, Emergency imports, Orphan drugs, Reference listed drugs, Comparator Drug and Name patient medicine, Bio-Similar and Innovator samples, etc.

What is Ceritinib or SPEXIB ™?

SPEXIB is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

Uses

Healthcare professionals recommend the drug Ceritinib in treating patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive.

Dosage

The capsules of Cetitinib come in 150 mg to administer orally. The general dosage of Cetitinib is 750 mg orally once daily until disease progression or unacceptable toxicity. Administer the drug Ceritinib at least 1 hour before or at least 2 hours after a meal.

Side Effects

The common side-effects of the drug Ceritinib are:

  • Increased thirst
  • Urinating often
  • Increased hunger
  • Blurred vision
  • Headaches
  • Tiredness
  • Breath smells like fruit